Datroway FDA Approval for First-Line Metastatic TNBC
Review the FDA approval of Datroway (datopotamab deruxtecan) for first-line metastatic TNBC. Analyze TROPION-Breast02 efficacy, survival, and safety data.
Back to Articles
Articles tagged with “fda-approval”
Tradipitant FDA Approval: Motion Sickness Drug Mechanism
Review the FDA approval of tradipitant for motion sickness. Explore the pharmacology of this NK-1 receptor antagonist and its 505(b)(2) regulatory pathway.
CTx-1301 Dexmethylphenidate: FDA Review & ADHD Clinical Data
Explore the clinical data and 505(b)(2) FDA regulatory pathway for CTx-1301 (dexmethylphenidate), a novel once-daily stimulant candidate for ADHD treatment.
Afrezza Pediatric FDA Approval: Inhaled Insulin for Children
Analyze the May 2026 FDA approval of Afrezza inhaled insulin for pediatric diabetes. Review INHALE-1 clinical trial data, T1D/T2D options, and market impacts.
Decnupaz FDA Approval: First CD123 ADC for BPDCN Therapy
Review the May 2026 FDA approval of Decnupaz (pivekimab sunirine), the first CD123-targeted ADC for BPDCN. Explores clinical efficacy and launch strategies.
Hepcludex FDA Approval: First Treatment for Hepatitis D
Review the FDA accelerated approval of Hepcludex (bulevirtide) for chronic hepatitis delta virus (HDV), including clinical trial data and public health impact.
Baxfendy (Baxdrostat) FDA Approval for Hypertension
Review the May 2026 FDA approval of Baxfendy (baxdrostat), analyzing its mechanism as an aldosterone synthase inhibitor for uncontrolled hypertension.
Beqalzi (Sonrotoclax) FDA Approval: BCL-2 Inhibitor for MCL
Examine the FDA accelerated approval of Beqalzi (sonrotoclax), the first BCL-2 inhibitor for relapsed mantle cell lymphoma, including efficacy and safety data.
Optune Pax: TTFields FDA Approval for Pancreatic Cancer
Review the 2026 FDA approval of Optune Pax (TTFields) for locally advanced pancreatic cancer. Explore PANOVA-3 trial survival data and mechanism of action.
Idvynso (Doravirine/Islatravir): Tenofovir-Free HIV Regimen
Examine the April 2026 FDA approval of Idvynso (doravirine/islatravir). Understand this tenofovir-free, two-drug HIV regimen's clinical efficacy and safety.
Tecartus FDA Approval: ZUMA-2 Data for Mantle Cell Lymphoma
Review the FDA full approval of Tecartus for relapsed mantle cell lymphoma. This analysis covers ZUMA-2 Cohort 3 efficacy data, CAR-T safety, and clinical use.
Otarmeni FDA Approval: OTOF Gene Therapy for Hearing Loss
Examine the FDA approval of Otarmeni, the first gene therapy for OTOF-related congenital hearing loss, and its expedited National Priority Voucher review.
AI in Radiology: 2025 Trends, FDA Approvals & Adoption
A 2025 overview of AI in radiology, covering FDA approvals, clinical adoption rates, and key technologies from CNNs to foundation models for medical imaging.